Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Total revenues | $ 6,618,110 | $ 5,015,868 | $ 20,471,026 | $ 17,218,131 |
| Total cost of sales | 3,724,776 | 2,673,933 | 11,783,455 | 9,082,349 |
| Gross profit | 2,893,334 | 2,341,935 | 8,687,571 | 8,135,782 |
| Operating expenses | ||||
| General and administrative | 2,343,449 | 2,473,190 | 7,642,183 | 7,365,495 |
| Selling | 567,529 | 656,885 | 1,572,221 | 1,747,959 |
| Research and development | 202,138 | 122,031 | 537,126 | 381,064 |
| Gain on disposition of assets | (5,486) | 0 | (41,931) | 0 |
| Gain on termination of unfavorable contract liability | (71,375) | 0 | ||
| Total operating expenses | 3,107,630 | 3,252,106 | 9,638,224 | 9,494,518 |
| Loss from operations | (214,296) | (910,171) | (950,653) | (1,358,736) |
| Other income (expense) | ||||
| Other income (expense), net | (7,140) | (4,798) | (22,556) | (7,127) |
| Interest expense | (2,280) | (3,855) | (15,841) | (13,583) |
| Gain on extinguishment of debt | 0 | (1,885,655) | 0 | 3,773,014 |
| Employee retention credit | 0 | 562,253 | 0 | (1,276,021) |
| Gain on sale | 0 | 6,046 | ||
| Unrealized gain (loss) on investment securities | 0 | (37,497) | 37,497 | 18,749 |
| Total other income (expense), net | (9,420) | 2,401,758 | (900) | 5,053,120 |
| Income (loss) before provision for state income taxes | (223,716) | 1,491,587 | (951,553) | 3,694,384 |
| Provision for state income taxes | 5,922 | 3,000 | 16,352 | 18,991 |
| Consolidated net income (loss) | (229,638) | 1,488,587 | (967,905) | 3,675,393 |
| Income attributable to the non-controlling interest | (27,074) | (21,890) | (55,616) | (42,358) |
| Net income (loss) attributable to Tecogen Inc. | $ (256,712) | $ 1,466,697 | $ (1,023,521) | $ 3,633,035 |
| Earnings Per Share [Abstract] | ||||
| Net income (loss) per share - basic (in USD per share) | $ (0.01) | $ 0.06 | $ (0.04) | $ 0.15 |
| Net income (loss) per share - diluted (in usd per share) | $ (0.01) | $ 0.06 | $ (0.04) | $ 0.14 |
| Weighted average shares outstanding - basic | 24,850,261 | 24,850,261 | 24,850,261 | 24,850,261 |
| Weighted average shares outstanding - diluted | 24,850,261 | 25,154,905 | 24,850,261 | 25,131,165 |
| Products | ||||
| Total revenues | $ 3,206,732 | $ 1,871,332 | $ 10,156,328 | $ 6,439,981 |
| Total cost of sales | 2,074,243 | 1,036,396 | 6,734,465 | 3,601,408 |
| Services | ||||
| Total revenues | 3,078,604 | 2,829,244 | 9,046,075 | 9,438,702 |
| Total cost of sales | 1,482,355 | 1,467,019 | 4,322,693 | 4,684,008 |
| Energy production | ||||
| Total revenues | 332,774 | 315,292 | 1,268,623 | 1,339,448 |
| Total cost of sales | $ 168,178 | $ 170,518 | $ 726,297 | $ 796,933 |
| X | ||||||||||
- Definition Employee Retention Credit No definition available.
|
| X | ||||||||||
- Definition Interest and Other Income (Expense) No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|